Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T14:57:21.718Z.
Calculation as of: 2026-10-06T14:57:21.718Z.
Quote observation: 2026-10-06T14:55:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a840c676881d241076febf00b391d6b63dc7604cd07ac1d060a0848db02ea459
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-03-27.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
8390802.46x
EV/SALES RATIO AVG 3Y
107.27x
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Inhibikase Therapeutics, Inc.
Market Cap
$260.77M
EV/Sales Ratio
N/A
TTM Avg
8390802.46x
3Y Avg
107.27x
5Y Avg
N/A
Market Cap
$262.48M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.58M
EV/Sales Ratio
10.75x
TTM Avg
42.40x
3Y Avg
29706.49x
5Y Avg
21359.19x
Market Cap
$263.68M
EV/Sales Ratio
62.96x
TTM Avg
74.23x
3Y Avg
31.36x
5Y Avg
21.18x
Market Cap
$256.35M
EV/Sales Ratio
2.00x
TTM Avg
1.60x
3Y Avg
1.66x
5Y Avg
1.91x
Market Cap
$266.10M
EV/Sales Ratio
1.05x
TTM Avg
0.74x
3Y Avg
0.47x
5Y Avg
0.82x
Market Cap
$255.32M
EV/Sales Ratio
N/A
TTM Avg
0.88x
3Y Avg
37.95x
5Y Avg
73.84x
Market Cap
$254.80M
EV/Sales Ratio
N/A
TTM Avg
495.70x
3Y Avg
495.70x
5Y Avg
495.70x
Market Cap
$272.91M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | $260.77M | N/A | 8390802.46x | 107.27x | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $262.48M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $262.58M | 10.75x | 42.40x | 29706.49x | 21359.19x |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $263.68M | 62.96x | 74.23x | 31.36x | 21.18x |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.35M | 2.00x | 1.60x | 1.66x | 1.91x |
| OraSure Technologies, Inc. (OSUR)vs › | $266.10M | 1.05x | 0.74x | 0.47x | 0.82x |
| Century Therapeutics, Inc. (IPSC)vs › | $255.32M | N/A | 0.88x | 37.95x | 73.84x |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $254.80M | N/A | 495.70x | 495.70x | 495.70x |
| Indaptus Therapeutics, Inc. (INDP)vs › | $272.91M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $274.50M | 48.95x | 36.37x | 26.31x | 30.77x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2025-03-27 | 20355142.90x |
| 2025-03-26 | 20532794.30x |
| 2025-03-25 | 20355142.90x |
| 2025-03-24 | 20355142.90x |
| 2025-03-21 | 20355142.90x |
| 2025-03-20 | 20799271.40x |
| 2025-03-19 | 21243399.90x |
| 2025-03-18 | 20355142.90x |
| 2025-03-17 | 20266317.20x |
| 2025-03-14 | 19289234.50x |
| 2025-03-13 | 18845106.00x |
| 2025-03-12 | 19111583.10x |
| 2025-03-11 | 18845106.00x |
| 2025-03-10 | 16979766.30x |
| 2025-03-07 | 16713289.20x |
| 2025-03-06 | 18045674.70x |
| 2025-03-05 | 19111583.10x |
| 2025-03-04 | 18845106.00x |
| 2025-03-03 | 19466885.90x |
| 2025-02-28 | 19733363.00x |
| 2025-02-27 | 20088665.80x |
| 2025-02-26 | 20443968.60x |
| 2025-02-25 | 19200408.80x |
| 2025-02-24 | 21332225.60x |
| 2025-02-21 | 25684684.90x |
| 2025-02-20 | 28260630.20x |
| 2025-02-19 | 26661767.60x |
| 2025-02-18 | 22398134.00x |
| 2025-02-14 | 20177491.50x |
| 2025-02-13 | 19111583.10x |
| 2025-02-12 | 19378060.20x |
| 2025-02-11 | 20088665.80x |
| 2025-02-10 | 20976922.80x |
| 2025-02-07 | 20177491.50x |
| 2025-02-06 | 20888097.10x |
| 2025-02-05 | 19999840.10x |
| 2025-02-04 | 19466885.90x |
| 2025-02-03 | 18489803.20x |
| 2025-01-31 | 19466885.90x |
| 2025-01-30 | 16357986.40x |
| 2025-01-29 | 24174648.00x |
| 2025-01-28 | 23819345.20x |
| 2025-01-27 | 23641693.80x |
| 2025-01-24 | 24263473.70x |
| 2025-01-23 | 24441125.10x |
| 2025-01-22 | 24174648.00x |
| 2025-01-21 | 24263473.70x |
| 2025-01-17 | 23464042.40x |
| 2025-01-16 | 23819345.20x |
| 2025-01-15 | 23552868.10x |
| 2025-01-14 | 22931088.20x |
| 2025-01-13 | 22931088.20x |
| 2025-01-10 | 25507033.50x |
| 2025-01-08 | 26839419.00x |
| 2025-01-07 | 27816501.70x |
| 2025-01-06 | 27372373.20x |
| 2025-01-03 | 28793584.40x |
| 2025-01-02 | 28527107.30x |
| 2024-12-31 | 28171804.50x |
| 2024-12-30 | 28082978.80x |
| 2024-12-27 | 26395290.50x |
| 2024-12-26 | 26484116.20x |
| 2024-12-24 | 25595859.20x |
| 2024-12-23 | 25595859.20x |
| 2024-12-20 | 27727676.00x |
| 2024-12-19 | 27372373.20x |
| 2024-12-18 | 31724832.50x |
| 2024-12-17 | 34567254.90x |
| 2024-12-16 | 31014226.90x |
| 2024-12-13 | 29859492.80x |
| 2024-12-12 | 28082978.80x |
| 2024-12-11 | 27727676.00x |
| 2024-12-10 | 27727676.00x |
| 2024-12-09 | 27816501.70x |
| 2024-12-06 | 28438281.60x |
| 2024-12-05 | 23552868.10x |
| 2024-12-04 | 23641693.80x |
| 2024-12-03 | 24174648.00x |
| 2024-12-02 | 23819345.20x |
| 2024-11-29 | 25240556.40x |
| 2024-11-27 | 23552868.10x |
| 2024-11-26 | 20266317.20x |
| 2024-11-25 | 20088665.80x |
| 2024-11-22 | 19822188.70x |
| 2024-11-21 | 17157417.70x |
| 2024-11-20 | 16890940.60x |
| 2024-11-19 | 17068592.00x |
| 2024-11-18 | 16802114.90x |
| 2024-11-15 | 17512720.50x |
| 2024-11-14 | 189.18x |
| 2024-11-13 | 194.86x |
| 2024-11-12 | 239.37x |
| 2024-11-11 | 237.48x |
| 2024-11-08 | 238.42x |
| 2024-11-07 | 228.95x |
| 2024-11-06 | 220.43x |
| 2024-11-05 | 216.64x |
| 2024-11-04 | 212.85x |
| 2024-11-01 | 215.69x |
| 2024-10-31 | 205.28x |
| 2024-10-30 | 228.01x |
| 2024-10-29 | 215.69x |
| 2024-10-28 | 225.16x |
| 2024-10-25 | 194.86x |
| 2024-10-24 | 204.33x |
| 2024-10-23 | 195.81x |
| 2024-10-22 | 165.50x |
| 2024-10-21 | 175.92x |
| 2024-10-18 | 167.39x |
| 2024-10-17 | 188.23x |
| 2024-10-16 | 149.40x |
| 2024-10-15 | 127.62x |
| 2024-10-14 | 116.25x |
| 2024-10-11 | 104.89x |
| 2024-10-10 | 88.79x |
| 2024-10-09 | 85.00x |
| 2024-10-08 | 78.37x |
| 2024-10-07 | 84.05x |
| 2024-10-04 | 85.00x |
| 2024-10-03 | 85.95x |
| 2024-10-02 | 79.32x |
| 2024-10-01 | 81.21x |
| 2024-09-30 | 88.79x |
| 2024-09-27 | 76.48x |
| 2024-09-26 | 74.58x |
| 2024-09-25 | 72.69x |
| 2024-09-24 | 74.58x |
| 2024-09-23 | 76.48x |
| 2024-09-20 | 79.32x |
| 2024-09-19 | 75.53x |
| 2024-09-18 | 76.48x |
| 2024-09-17 | 75.53x |
| 2024-09-16 | 75.53x |
| 2024-09-13 | 77.43x |
| 2024-09-12 | 79.32x |
| 2024-09-11 | 90.68x |
| 2024-09-10 | 92.58x |
| 2024-09-09 | 97.31x |
| 2024-09-06 | 92.58x |
| 2024-09-05 | 94.47x |
| 2024-09-04 | 93.52x |
| 2024-09-03 | 92.58x |
| 2024-08-30 | 98.26x |
| 2024-08-29 | 97.31x |
| 2024-08-28 | 96.37x |
| 2024-08-27 | 98.26x |
| 2024-08-26 | 103.00x |
| 2024-08-23 | 101.10x |
| 2024-08-22 | 95.42x |
| 2024-08-21 | 103.00x |
| 2024-08-20 | 99.21x |
| 2024-08-19 | 86.90x |
| 2024-08-16 | 85.95x |
| 2024-08-15 | 82.16x |
| 2024-08-14 | 32.55x |
| 2024-08-13 | 35.14x |
| 2024-08-12 | 33.20x |
| 2024-08-09 | 31.91x |
| 2024-08-08 | 32.23x |
| 2024-08-07 | 31.58x |
| 2024-08-06 | 32.88x |
| 2024-08-05 | 31.91x |
| 2024-08-02 | 33.52x |
| 2024-08-01 | 34.82x |
| 2024-07-31 | 36.11x |
| 2024-07-30 | 37.08x |
| 2024-07-29 | 40.64x |
| 2024-07-26 | 42.26x |
| 2024-07-25 | 42.26x |
| 2024-07-24 | 43.55x |
| 2024-07-23 | 40.96x |
| 2024-07-22 | 38.38x |
| 2024-07-19 | 39.02x |
| 2024-07-18 | 37.73x |
| 2024-07-17 | 38.70x |
| 2024-07-16 | 40.32x |
| 2024-07-15 | 38.70x |
| 2024-07-12 | 37.73x |
| 2024-07-11 | 34.49x |
| 2024-07-10 | 32.88x |
| 2024-07-09 | 33.85x |
| 2024-07-08 | 34.17x |
| 2024-07-05 | 28.02x |
| 2024-07-03 | 27.70x |
| 2024-07-02 | 29.64x |
| 2024-07-01 | 30.61x |
| 2024-06-28 | 29.64x |
| 2024-06-27 | 34.82x |
| 2024-06-26 | 36.11x |
| 2024-06-25 | 35.46x |
| 2024-06-24 | 33.52x |
| 2024-06-21 | 35.79x |
| 2024-06-20 | 36.76x |
| 2024-06-18 | 38.70x |
| 2024-06-17 | 41.94x |
| 2024-06-14 | 36.11x |
| 2024-06-13 | 39.99x |
| 2024-06-12 | 41.61x |
| 2024-06-11 | 42.26x |
| 2024-06-10 | 43.23x |
| 2024-06-07 | 45.17x |
| 2024-06-06 | 44.20x |
| 2024-06-05 | 46.46x |
| 2024-06-04 | 49.38x |
| 2024-06-03 | 50.67x |
| 2024-05-31 | 50.02x |
| 2024-05-30 | 49.05x |
| 2024-05-29 | 49.05x |
| 2024-05-28 | 47.44x |
| 2024-05-24 | 49.05x |
| 2024-05-23 | 49.70x |
| 2024-05-22 | 51.64x |
| 2024-05-21 | 51.64x |
| 2024-05-20 | 50.67x |
| 2024-05-17 | 46.46x |
| 2024-05-16 | 47.44x |
| 2024-05-15 | 14.46x |
| 2024-05-14 | 3.78x |
| 2024-05-08 | 0.45x |
| 2024-05-03 | 0.21x |
| 2024-04-30 | 2.11x |
| 2024-04-29 | 4.96x |
| 2024-04-26 | 7.81x |
| 2024-04-25 | 12.33x |
| 2024-04-24 | 11.61x |
| 2024-04-23 | 4.73x |
| 2024-04-19 | 15.65x |
| 2024-04-18 | 17.07x |
| 2024-04-17 | 17.79x |
| 2024-04-16 | 17.79x |
| 2024-04-15 | 19.21x |
| 2024-04-12 | 19.21x |
| 2024-04-11 | 20.64x |
| 2024-04-10 | 18.26x |
| 2024-04-09 | 17.79x |
| 2024-04-08 | 19.69x |
| 2024-04-05 | 19.45x |
| 2024-04-04 | 19.45x |
| 2024-04-03 | 18.26x |
| 2024-04-02 | 18.26x |
| 2024-04-01 | 18.50x |
| 2024-03-28 | 18.50x |
| 2024-02-08 | 0.31x |
| 2024-02-06 | 4.10x |
| 2024-01-31 | 4.76x |
| 2024-01-30 | 6.90x |
| 2024-01-29 | 7.89x |
| 2024-01-26 | 3.77x |
| 2024-01-24 | 3.77x |
| 2023-11-14 | 13.96x |
| 2023-11-13 | 13.07x |
| 2023-11-10 | 14.37x |
| 2023-11-09 | 14.37x |
| 2023-11-08 | 15.83x |
| 2023-11-07 | 16.03x |
| 2023-11-06 | 15.00x |
| 2023-11-03 | 15.00x |
| 2023-11-02 | 16.03x |
| 2023-11-01 | 11.26x |
| 2023-10-31 | 12.00x |
Showing the most recent 260 of 567 data points. The chart above shows the full history.
